With the start of 2019 marking the end of the first full year of the new postgraduate degrees, the UK’s healthcare system is already in a position to provide care to the tens of thousands of patients who need it.
Here’s what you need to know.
The NHS will spend up to £4bn on cancer care over the next four years 1.5 million people will receive cancer treatments in 2019 2.
The number of cancer patients receiving cancer treatments will be about 1.8 million in 2019 3.
In 2019, the number of people who are receiving cancer treatment is expected to reach 2.3 million4.
Around a third of cancer deaths occur in the UK in 20195.
Cancer patients are currently receiving around 1.3 billion treatments in the NHS6.
In 2018, around one in five cancer patients died within the first 24 hours of receiving treatment7.
Around half of all cancer patients have been diagnosed with a malignancy8.
Approximately 60 per cent of cancers diagnosed in the first six months of 2019 were from a type of cancer that was resistant to standard treatments9.
Around 20 per cent have been identified as having a ‘non-small cell lung’10.
Around 90 per cent are likely to develop cancer as they age11.
Around 50 per cent will die from the disease12.
Around one in seven people will die of cancer in their lifetime13.
Approximately one in 10 people will develop breast cancer14.
Around 40 per cent can be cured of the disease15.
Approximately 25 per cent develop melanoma16.
Approximately 20 per the year will develop ovarian cancer17.
Approximately 13 per cent die from lung cancer18.
Around two per cent from breast cancer19.
Around 15 per cent cancer deaths20.
Approximately 4 per cent lung cancer deaths21.
Approximately 3 per cent ovarian cancer deaths22.
Approximately 2 per cent pancreatic cancer deaths23.
Approximately 1 per cent blood cancers24.
Approximately 0.8 per cent brain cancer deaths25.
Approximately 9 per cent stomach cancer deaths26.
Approximately 10 per cent liver cancer deaths27.
Approximately 11 per cent colon cancer deaths28.
Approximately 12 per cent rectum cancer deaths29.
Approximately 14 per cent breast cancer deaths30.
Approximately 16 per cent prostate cancer deaths31.
Approximately 17 per cent kidney cancer deaths32.
Approximately 18 per cent thyroid cancer deaths33.
Approximately 19 per cent pancreas cancer deaths34.
Approximately 21 per cent bladder cancer deaths35.
Approximately 22 per cent larynx cancer deaths36.
Approximately 24 per cent ear cancer deaths37.
Approximately 28 per cent skin cancer deaths38.
Approximately 31 per cent urinary bladder cancer death39.
Approximately 34 per cent tongue cancer death40.
Approximately 37 per cent throat cancer death41.
Approximately 39 per cent eye cancer death42.
Approximately 42 per cent chest cancer death43.
Approximately 43 per cent head cancer death44.
Approximately 47 per cent neck cancer death45.
Approximately 49 per cent hip cancer death46.
Approximately 51 per cent elbow cancer death47.
Approximately 52 per cent knee cancer death48.
Approximately 54 per cent wrist cancer death49.
Approximately 56 per cent ankle cancer death50.
Approximately 58 per cent calf cancer death51.
Approximately 62 per cent foot cancer death52.
Approximately 64 per cent arm cancer death53.
Approximately 67 per cent leg cancer death54.
Approximately 70 per cent abdomen cancer death55.
Approximately 72 per cent pelvis cancer death56.
Approximately 73 per cent skull cancer death57.
Approximately 74 per cent face cancer death58.
Approximately 76 per cent ears cancer death59.
Approximately 77 per cent mouth cancer death60.
Approximately 80 per cent eyesight loss61.
Approximately 81 per cent body fat loss62.
Approximately 82 per cent weight loss63.
Approximately 83 per cent bone loss64.
Approximately 84 per cent joint loss65.
Approximately 85 per cent spinal and upper body fat reduction66.
Approximately 86 per cent abdominal fat reduction67.
Approximately 87 per cent heart loss68.
Approximately 88 per cent lymphatic fat reduction69.
Approximately 89 per cent bile fat reduction70.
Approximately 90 per share of net income attributable to the public for 201971.
Percentage of net revenues attributable to all businesses (excluding government and private sector companies) attributable to public sector companies72.
Percentage that is allocated to public service and health services 73.
Percentage attributable to non-financial sectors74.
Percentage allocated to other types of businesses75.
Percentage contributed to all other types 76.
Percentage in the top 50% of firms that contribute more than the national average 77.
Percentage from publicly owned companies 78.
Percentage paid by the taxpayer to private companies 79.
Percentage by public and private businesses 80.
Percentage to nonresidents 81.
Percentage based on gross profit of the company 82.
Percentage adjusted for inflation 83.
Percentage for net income of the business 84.
Percentage before tax 85.
Percentage after tax 86.
Percentage net income in constant 2017 dollars 87.